semaglutide cause liver damage Weight loss drugs could also battle disease Diabetes and obesity drug shows

Newsletter Signup - Under Article / In Page "*" indicates required fields In 2020, Novo Nordisks Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired

Abdominal pain and bloating, cardinal features of IBS, may also be affected by Wegovy

Meanwhile, oral forms are steadily gaining traction, appealing to those who prefer a non-injection alternative, though they currently represent a smaller portion of the market

For the right patient, these therapies may complement nutrition, exercise, and hormonal balancenot replace themto support sustainable fat loss under a physicians care